Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia

Schizophrenia Bulletin

Volumn 38, Issue 6, 2012, Pages 1137-1148

  Prasad, Konasale M ^a   Watson, Annie M M ^a,b   Dickerson, Faith B ^c   Yolken, Robert H ^d   Nimgaonkar, Vishwajit L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c SHEPPARD PRATT HEALTH SYSTEM   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cognition; herpes; HSV1; neuroimaging; neuroscience; schizophrenia

Indexed keywords

ANTIVIRUS AGENT; NEUROLEPTIC AGENT; PLACEBO; VALACICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL PROTOCOL; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; EXECUTIVE FUNCTION; EXPOSURE; GRAY MATTER; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEROLOGY; TEMPORAL CORTEX; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

BRAIN; COGNITION DISORDERS; EXECUTIVE FUNCTION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MEMORY, SHORT-TERM; SCHIZOPHRENIA;

EID: 84867507735     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs046     Document Type: Article

References (52)

1. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168: 472-485.
2. Wykes T, Huddy V. Cognitive remediation for schizophrenia: it is even more complicated. Curr Opin Psychiatry. 2009; 22:161-167.
3. Becker Y. HSV-1 brain infection by the olfactory nerve route and virus latency and reactivation may cause learning and behavioral deficiencies and violence in children and adults: a point of view. Virus Genes. 1995;10:217-226.
4. Daheshia M, Feldman LT, Rouse BT. Herpes simplex virus latency and the immune response. Curr Opin Microbiol. 1998;1:430-435.
5. Reuter JD, Wilson JH, Idoko KE, van den Pol AN. CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain. J Virol. 2005;79:9527-9539.
6. Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol. 1994;36:823-829.
7. Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007;6:1015-1028.
8. Prevention CfDCa. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm. Accessed December 10, 2010.
9. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(suppl 1):S3-S28.
10. Bergstrom T, Trybala E. Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for typespecific serology. Intervirology. 1996;39:176-184.
11. Hill JM, Ball MJ, Neumann DM, et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol. 2008;82:8230-8234.
12. LiedtkeW, Opalka B, Zimmermann CW, Lignitz E. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci. 1993;116:6-11.
13. Hokkanen L, Launes J. Cognitive outcome in acute sporadic encephalitis. Neuropsychol Rev. 2000;10:151-167.
14. Borgo F, Sgaramella TM, Penello B, L'Erario R, Toso V. A componential analysis of visual object recognition deficits in patients with herpes simplex virus encephalitis. Brain Cogn. 2000;43:53-56.
15. Beers DR, Henkel JS, Kesner RP, Stroop WG. Spatial recognition memory deficits without notable CNS pathology in rats following herpes simplex encephalitis. J Neurol Sci. 1995;131:119-127.
16. Yolken RH, Torrey EF. Viruses, schizophrenia and bipolar disorder. Clin Microbiol Rev. 1995;8:131-145.
17. Delisi LE, Smith SB, Hamovit JR, et al. Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychol Med. 1986;16:757-763.
18. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010;167:261-280.
19. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 2003;60:466-472.
20. Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res. 2008;106:268-274.
21. Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res. 2011;128:61-65.
22. Gur RC, Ragland JD, Moberg PJ, et al. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology. 2001;25:777-788.
23. Gur RE, Nimgaonkar VL, Almasy L, et al. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry. 2007;164:813-819.
24. Schretlen DJ, Vannorsdall TD, Winicki JM, et al. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophr Res. 2010;118:224-231.
25. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res. 2012;134: 83-88.
26. Dickerson FB, Boronow JJ, Stallings C, et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry. 2004;55:588-593.
27. Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003; 34:2126-2131.
28. Dickerson F, Stallings C, Sullens A, et al. Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain Behav Immun. 2008;22:1103-1107.
29. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:1046-1054.
30. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25:242-244.
31. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med. 2011;13:e30.
32. Itzhaki R. Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease. Herpes. 2004;11(suppl 2):77A-82A.
33. Prasad KM, Eack SM, Keshavan MS, Yolken RH, Iyengar S, Nimgaonkar VL. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. [published online ahead of print March 23, 2012]. Schizophr Bull. doi:10.1093/schbul/ SBS040.
34. Pandurangi AK, Pelonero AL, Nadel L, Calabrese VP. Brain structure changes in schizophrenics with high serum titers of antibodies to herpes virus. Schizophr Res. 1994;11:245-250.
35. Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry. 2007;12:105-113, 101.
36. Chetelat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage. 2005;27:934-946.
37. Kim DI, Manoach DS, Mathalon DH, et al. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp. 2009;30:3795-3811.
38. Millhouse S, Wigdahl B. Molecular circuitry regulating herpes simplex virus type 1 latency in neurons. J Neurovirol. 2000;6:6-24.
39. Jarskog LF. Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr Opin Psychiatry. 2006; 19:307-312.
40. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch GenPsychiatry. 2009;66:811-822.
41. Hill A. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
42. Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol. 1997;24:151-160.
43. ZhangXW, Li F,YuXW, ShiXW, Shi J,Zhang JP.Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol. 2007;40:180-185.
44. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics. 2006;117:1955-1962.
45. Brown AS, Vinogradov S, Kremen WS, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry. 2009;166:683-690.
46. Koi H, Zhang J, Makrigiannakis A, et al. Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus. Biol Reprod. 2002;67:1572-1579.
47. Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev. 2009;33:1061-1079.
48. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56.
49. Li H, Zhang J, Kumar A, Zheng M, Atherton SS, Yu FS. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology. 2006;117:167-176.
50. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW. Interleukin-6 facilitates lipopolysaccharideinduced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci. 2006;26:10709-10716.
51. Szpara ML, Kobiler O, Enquist LW. A common neuronal response to alphaherpesvirus infection. J Neuroimmune Pharmacol. 2010;5:418-427.
52. Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull. 2009;35:1163-1182.